The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RNAseq and DNA whole-exome sequence analysis reveal novel response signatures to IO treatment in muscle invasive bladder cancer (MIBC) patients.
 
Gregory Mayhew
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Research Funding - GeneCentric
Patents, Royalties, Other Intellectual Property - I hold no patents. But just in case want to say I've signed legal documents for the company I am employed by (GeneCentric Therapeutics) transferring patent rights associated with inventions I've worked on to the company.
Travel, Accommodations, Expenses - GeneCentric
 
Yoichiro Shibata
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Research Funding - GeneCentric
Patents, Royalties, Other Intellectual Property - Patent pending for Tumor Mutation Burden (TMB) from RNA-seq
 
Joshua M Uronis
Employment - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Consulting or Advisory Role - Bristol-Myers Squibb (I)
Research Funding - Advaxis (I); Bristol-Myers Squibb (I); Macrogenics (I); Merck (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (I)
 
Michele C Hayward
No Relationships to Disclose
 
Tracy L Rose
Research Funding - Bristol-Myers Squibb; GeneCentric; Roche/Genentech; X4 Pharma
 
William Y. Kim
Stock and Other Ownership Interests - Abbvie; Amgen; BeiGene; Bristol-Myers Squibb; FibroGen; G1 Therapeutics; Illumina; Johnson & Johnson; Kura Oncology; Spectrum Pharmaceuticals
Honoraria - Takeda
Consulting or Advisory Role - Foundation Medicine; GeneCentric
Research Funding - Foundation Medicine; GeneCentric; Merck
Patents, Royalties, Other Intellectual Property - BASE47 bladder cancer subtype classifier
Travel, Accommodations, Expenses - Takeda
 
Charles M. Perou
Leadership - Bioclassifier; GeneCentric
Stock and Other Ownership Interests - Bioclassifier; GeneCentric
Consulting or Advisory Role - Bioclassifier; G1 Therapeutics; GeneCentric; Ions Pharmaceuticals
Patents, Royalties, Other Intellectual Property - royalties from PAM50 breast cancer gene patent application, and from lung gene signature patent
Travel, Accommodations, Expenses - Chugai Pharma; Takeda
 
Myla Lai-Goldman
Employment - GeneCentric; Takeda (I)
Leadership - West Pharmaceutical
Stock and Other Ownership Interests - GeneCentric; Takeda (I); West Pharmaceutical
Consulting or Advisory Role - Personalized Science
Research Funding - GeneCentric
Patents, Royalties, Other Intellectual Property - GeneCentric
Travel, Accommodations, Expenses - West Pharmaceutical
 
Michael Vance Milburn
Employment - GeneCentric; Metabolon
Leadership - GeneCentric; Metabolon
Stock and Other Ownership Interests - GeneCentric; Metabolon
Research Funding - GeneCentric; Metabolon
Patents, Royalties, Other Intellectual Property - GeneCentric; Metabolon